Please use this identifier to cite or link to this item: http://hdl.handle.net/10201/22534

Title: Hepatocyte growth factor/scatter factor and prostate cancer: a review
Issue Date: 2005
Publisher: Murcia : F. Hernández
ISSN: 0213-3911
Related subjects: CDU::6 - Ciencias aplicadas::61 - Medicina::616 - Patología. Medicina clínica. Oncología::616.6 - Patología del sistema genitourinario
Keywords: Hepatocyte growth factor
Prostate cancer
Abstract: Men who die from prostate cancer do so from uncontrolled metastatic disease. A better understanding of the mechanisms involved in the progression and metastasis of prostate cancer may lead to novel therapeutic approaches to prevent its natural progression. Hepatocyte Growth Factor / Scatter factor (HGF/SF) has been demonstrated to elicit a number of key functions in numerous tissues that are important in the progression, invasion and metastasis of cancer. Studies have demonstrated that the activity of HGF/SF and its receptor c-Met are linked to disease progression in numerous cancers. However, research into these functions, which include activities as a mitogen, a motogen and an anti-apoptotic and angiogenic factor in prostate cancer are limited. This article reviews the published evidence of the roles HGF/SF plays in prostate cancer progression and highlights the clinical and therapeutic potential of research into this pleiomorphic cytokine.
Primary author: Hurle, R.A.
Davies, Graham
Parr, C.
Mason, M.D.
Jenkins, S.A.
Kynaston, H.G.
Jiang, W.G.
Published in: Histology and histopathology
URI: http://hdl.handle.net/10201/22534
Document type: info:eu-repo/semantics/article
Number of pages / Extensions: 11
Rights: info:eu-repo/semantics/openAccess
Appears in Collections:Vol.20, nº 4 (2005)

Files in This Item:
File Description SizeFormat 
Hepatocyte growth factor scatter.pdf800,71 kBAdobe PDFThumbnail
View/Open


Items in Digitum are protected by copyright, with all rights reserved, unless otherwise indicated.